ORKA Q3 2023 Earnings — Oruka Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ORKAOruka Therapeutics, Inc.

$1B

Q3 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$30,000

Operating Income

-$2M

Net Income

-$1M

EPS (Diluted)

$-1.19

QoQ Revenue Growth

NaN%

Balance Sheet

Total Assets

$39M

Total Liabilities

$1M

Stockholders' Equity

$38M

Cash & Equivalents

$38M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$30,000	-$28,000	-7.1%
Operating Income	-$2M	-$2M	-9.9%
Net Income	-$1M	-$2M	+39.0%